Simon Quick Advisors LLC Invests $148,000 in Haleon PLC Sponsored ADR $HLN

Simon Quick Advisors LLC acquired a new position in shares of Haleon PLC Sponsored ADR (NYSE:HLN) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 14,309 shares of the company’s stock, valued at approximately $148,000.

Several other large investors also recently modified their holdings of the stock. Private Trust Co. NA grew its position in shares of Haleon by 13.3% during the 2nd quarter. Private Trust Co. NA now owns 8,794 shares of the company’s stock worth $91,000 after buying an additional 1,032 shares during the period. Apollon Wealth Management LLC grew its position in shares of Haleon by 5.4% during the 1st quarter. Apollon Wealth Management LLC now owns 21,722 shares of the company’s stock worth $224,000 after buying an additional 1,111 shares during the period. Holistic Financial Partners boosted its holdings in Haleon by 9.6% in the first quarter. Holistic Financial Partners now owns 13,379 shares of the company’s stock worth $138,000 after acquiring an additional 1,172 shares in the last quarter. AE Wealth Management LLC boosted its holdings in Haleon by 6.5% in the first quarter. AE Wealth Management LLC now owns 19,323 shares of the company’s stock worth $199,000 after acquiring an additional 1,186 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC boosted its holdings in Haleon by 4.0% in the second quarter. Allspring Global Investments Holdings LLC now owns 31,423 shares of the company’s stock worth $321,000 after acquiring an additional 1,200 shares in the last quarter. Institutional investors and hedge funds own 6.67% of the company’s stock.

Haleon Price Performance

Shares of NYSE:HLN opened at $9.34 on Wednesday. The company has a current ratio of 0.87, a quick ratio of 0.63 and a debt-to-equity ratio of 0.48. The stock’s fifty day simple moving average is $9.30 and its two-hundred day simple moving average is $9.94. Haleon PLC Sponsored ADR has a 1-year low of $8.71 and a 1-year high of $11.42. The stock has a market cap of $41.57 billion, a PE ratio of 23.94, a price-to-earnings-growth ratio of 2.81 and a beta of 0.20.

Analysts Set New Price Targets

Several brokerages have issued reports on HLN. Barclays lowered Haleon from an “overweight” rating to an “equal weight” rating in a report on Tuesday, September 16th. Wall Street Zen lowered Haleon from a “buy” rating to a “hold” rating in a report on Saturday, July 12th. Weiss Ratings reiterated a “hold (c)” rating on shares of Haleon in a report on Wednesday, October 8th. Finally, The Goldman Sachs Group upgraded Haleon from a “neutral” rating to a “buy” rating in a report on Wednesday, September 10th. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat, Haleon currently has an average rating of “Moderate Buy” and an average target price of $12.33.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.